2022
DOI: 10.1097/adm.0000000000000966
|View full text |Cite
|
Sign up to set email alerts
|

A Case of Phenibut Directed Detoxification Leading to Toxicity During the COVID-19 Pandemic

Abstract: Background: Phenibut is a non-Food and Drug Administrationapproved gamma-aminobutyric acid analog marketed in the United States as an anxiolytic, cognitive enhancer, and alcohol withdrawal treatment through online supplement vendors. In this case report, we describe a woman's self-directed detoxification with phenibut used to manage withdrawal symptoms from fentanyl and benzodiazepines in March 2020 during the height of the COVID-19 pandemic. Case: A 38-year-old woman with severe opioid, benzodiazepine, gabape… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
references
References 15 publications
0
0
0
Order By: Relevance